Derry Christopher J, Derry Sheena, Moore R Andrew
Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Cochrane Database Syst Rev. 2013 Jun 24;2013(6):CD010210. doi: 10.1002/14651858.CD010210.pub2.
Combining two different analgesics in fixed doses in a single tablet can provide better pain relief than either drug alone in acute pain. This appears to be broadly true across a range of different drug combinations, in postoperative pain and migraine headache. Some combinations of ibuprofen and paracetamol are available for use without prescription in some acute pain situations.
To assess the efficacy and adverse effects of single dose oral ibuprofen plus paracetamol for acute postoperative pain using methods that permit comparison with other analgesics evaluated in standardised trials using almost identical methods and outcomes.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library (Issue 4 of 12, 2013), MEDLINE (1950 to May 21st 2013), EMBASE (1974 to May 21st 2013), the Oxford Pain Database, ClinicalTrials.gov, and reference lists of articles.
Randomised, double-blind clinical trials of single dose, oral ibuprofen plus paracetamol compared with placebo or the same dose of ibuprofen alone for acute postoperative pain in adults.
Two review authors independently considered trials for inclusion in the review, assessed quality, and extracted data. We used validated equations to calculate the area under the pain relief versus time curve and derive the proportion of participants with at least 50% of maximum pain relief over six hours. We calculated relative risk (RR) and number needed to treat to benefit (NNT) for ibuprofen plus paracetamol, ibuprofen alone, or placebo. We used information on use of rescue medication to calculate the proportion of participants requiring rescue medication and the weighted mean of the median time to use. We also collected information on adverse events.
Searches identified three studies involving 1647 participants. Each of them examined several dose combinations. Included studies provided data from 508 participants for the comparison of ibuprofen 200 mg + paracetamol 500 mg with placebo, 543 participants for the comparison of ibuprofen 400 mg + paracetamol 1000 mg with placebo, and 359 participants for the comparison of ibuprofen 400 mg + paracetamol 1000 mg with ibuprofen 400 mg alone.The proportion of participants achieving at least 50% maximum pain relief over 6 hours was 69% with ibuprofen 200 mg + paracetamol 500 mg, 73% with ibuprofen 400 mg + paracetamol 1000 mg, and 7% with placebo, giving NNTs of 1.6 (1.5 to 1.8) and 1.5 (1.4 to 1.7) for the lower and higher doses respectively compared with placebo. For ibuprofen 400 mg alone the proportion was 52%, giving an NNT for ibuprofen 400 mg + paracetamol 1000 mg compared with ibuprofen alone of 5.4 (3.5 to 12).Ibuprofen + paracetamol at the 200/500 mg and 400/1000 mg doses resulted in longer times to remedication than placebo. The median time to use of rescue medication was 7.6 hours for ibuprofen 200 mg + paracetamol 500 mg, 8.3 hours with ibuprofen 400 mg + paracetamol 1000 mg, and 1.7 hours with placebo. Fewer participants needed rescue medication with ibuprofen + paracetamol combination than with placebo or ibuprofen alone. The proportion was 34% with ibuprofen 200 mg + paracetamol 500 mg, 25% with ibuprofen 400 mg + paracetamol 1000 mg, and 79% with placebo, giving NNTs to prevent use of rescue medication of 2.2 (1.8 to 2.9) and 1.8 (1.6 to 2.2) respectively compared with placebo. The proportion of participants using rescue medication with ibuprofen 400 mg was 48%, giving an NNT to prevent use for ibuprofen 400 mg + paracetamol 1000 mg compared with ibuprofen alone of 4.3 (3.0 to 7.7).The proportion of participants experiencing one or more adverse events was 30% with ibuprofen 200 mg + paracetamol 500 mg, 29% with ibuprofen 400 mg + paracetamol 1000 mg, and 48% with placebo, giving NNT values in favour of the combination treatment of 5.4 (3.6 to 10.5) and 5.1 (3.5 to 9.5) for the lower and higher doses respectively. No serious adverse events were reported in any of the included studies. Withdrawals for reasons other than lack of efficacy were fewer than 5% and balanced across treatment arms.
AUTHORS' CONCLUSIONS: Ibuprofen plus paracetamol combinations provided better analgesia than either drug alone (at the same dose), with a smaller chance of needing additional analgesia over about eight hours, and with a smaller chance of experiencing an adverse event.
在一片药片中固定剂量联合使用两种不同的镇痛药,在急性疼痛中比单独使用任何一种药物能提供更好的疼痛缓解效果。在术后疼痛和偏头痛中,对于一系列不同的药物组合,情况似乎大致如此。在一些急性疼痛情况下,某些布洛芬和对乙酰氨基酚的组合无需处方即可使用。
采用能与使用几乎相同方法和结果的标准化试验中评估的其他镇痛药进行比较的方法,评估单剂量口服布洛芬加对乙酰氨基酚治疗急性术后疼痛的疗效和不良反应。
我们检索了Cochrane图书馆(2013年第4期,共12期)中的Cochrane对照试验中心注册库(CENTRAL)、MEDLINE(1950年至2013年5月21日)、EMBASE(1974年至2013年5月21日)、牛津疼痛数据库、ClinicalTrials.gov以及文章的参考文献列表。
将单剂量口服布洛芬加对乙酰氨基酚与安慰剂或相同剂量的布洛芬单独用于成人急性术后疼痛的随机、双盲临床试验。
两位综述作者独立考虑纳入综述的试验,评估质量并提取数据。我们使用经过验证的公式计算疼痛缓解与时间曲线下的面积,并得出在6小时内达到最大疼痛缓解至少50%的参与者比例。我们计算了布洛芬加对乙酰氨基酚、单独使用布洛芬或安慰剂的相对风险(RR)和需治疗获益人数(NNT)。我们利用急救药物使用信息计算需要急救药物的参与者比例以及使用急救药物的中位时间加权平均值。我们还收集了不良事件的信息。
检索确定了三项研究,涉及1647名参与者。每项研究都考察了几种剂量组合。纳入研究提供了508名参与者的数据用于比较布洛芬200毫克 + 对乙酰氨基酚500毫克与安慰剂,543名参与者的数据用于比较布洛芬400毫克 + 对乙酰氨基酚1000毫克与安慰剂,以及359名参与者的数据用于比较布洛芬400毫克 + 对乙酰氨基酚1000毫克与单独使用布洛芬400毫克。在6小时内达到最大疼痛缓解至少50%的参与者比例,布洛芬200毫克 + 对乙酰氨基酚500毫克组为69%,布洛芬400毫克 + 对乙酰氨基酚1000毫克组为73%;安慰剂组为7%。与安慰剂相比,较低和较高剂量组的NNT分别为1.6(1.5至1.8)和1.5(1.4至1.7)。单独使用布洛芬(400毫克)组这一比例为52%,布洛芬400毫克 + 对乙酰氨基酚1000毫克组与单独使用布洛芬400毫克相比,NNT为5.4(3.5至12)。
布洛芬200/500毫克和400/1000毫克剂量组合导致再次用药时间比安慰剂更长。使用急救药物的中位时间,布洛芬200毫克 + 对乙酰氨基酚500毫克组为7.6小时,布洛芬400毫克 + 对乙酰氨基酚1000毫克组为8.3小时,安慰剂组为1.7小时。与安慰剂或单独使用布洛芬相比,使用布洛芬加对乙酰氨基酚组合的参与者需要急救药物的人数更少。布洛芬200毫克 + 对乙酰氨基酚500毫克组这一比例为34%,布洛芬400毫克 + 对乙酰氨基酚1000毫克组为25%,安慰剂组为79%。与安慰剂相比,预防使用急救药物的NNT分别为2.2(1.8至2.9)和1.8(1.6至2.2)。使用布洛芬400毫克的参与者使用急救药物的比例为48%,布洛芬400毫克 + 对乙酰氨基酚1000毫克组与单独使用布洛芬400毫克相比,预防使用急救药物的NNT为4.3(3.0至7.7)。
经历一种或多种不良事件的参与者比例,布洛芬200毫克 + 对乙酰氨基酚500毫克组为30%,布洛芬400毫克 + 对乙酰氨基酚1000毫克组为29%,安慰剂组为48%。较低和较高剂量组支持联合治疗的NNT值分别为5.4(3.6至10.5)和5.1(3.5至9.5)。纳入的任何研究均未报告严重不良事件。因缺乏疗效以外的原因退出的比例低于5%,且各治疗组之间均衡。
布洛芬加对乙酰氨基酚组合比单独使用任何一种药物(相同剂量)镇痛效果更好,在约八小时内需要额外镇痛的可能性更小,且发生不良事件的可能性更小。